Gene therapy in mental retardation: ethical considerations.
D002648:Child; D003068:Coercion; D030881:Disclosure; D026724:Ethical Review; D004989:Ethics; D017041:Ethics Committees; D028744:Ethics Committees, Research; D035082:Federal Government; D030342:Genetic Diseases, Inborn; D005818:Genetic Engineering; D024861:Genetic Enhancement; D036281:Genetic Research; D015316:Genetic Therapy; D005823:Genetics; D005854:Germ Cells; D006076:Government; D033161:Government Regulation; D017408:Guidelines as Topic; D015276:Health Care Rationing; D006664:History; D049673:History, 20th Century; D006805:Human Experimentation; D006801:Humans; D007223:Infant; D007258:Informed Consent; D007360:Intelligence; D016743:Mental Competency; D008722:Methods; D033282:Parental Consent; D018579:Patient Selection; D019989:Persons with Intellectual Disabilities; D035842:Research Subjects; D040841:Resource Allocation; D012306:Risk; D018570:Risk Assessment; D015871:Scientific Misconduct; D012926:Social Control, Formal; D012935:Social Justice; D020458:Third-Party Consent; D014481:United States
Biomedical and Behavioral Research; Genetics and Reproduction; Mental Health Therapies